MARATTO

article · Benha Medical Journal

Platelet-Lymphocyte Ratio in Predicting Mortality of Patients in Pediatric Intensive Care Unit

2024Open accessBenha University

Abstract

Background: Pediatric intensive care units (PICU) have special equipment for treatment of children with life-threatening conditions Platelet-lymphocyte ratio (PLR) is a novel inflammatory marker. It has been shown that PLR can be used as a useful marker for early diagnosis and treatment of some diseases. This study aimed to research whether PLR is a predictive factor of mortality risk in PICU patients. Methods: This retrospective and prospective observational cohort study was conducted on 100 children hospitalized in the PICU in Benha University Hospitals. Patients were evaluated by different disease severity scores using sequential organ failure assessment (SOFA), pediatric index of mortality 2 score (PIM2), preserved ratio impaired spirometry (PRISM III) and pediatric logistic organ dysfunction (PELOD). Results: PLR, and NLR were significantly lower in non- survivors compared to survivors (P

Research topics

  • Inflammatory Biomarkers in Disease Prognosis
  • Statistical Methods in Epidemiology
  • Venous Thromboembolism Diagnosis and Management

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/bmfj.2024.317372.2189

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.